These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 18065333)

  • 1. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N; Tavil Y; Erdamar H; Yazici HU; Cakir E; Akgül EO; Bilgi C; Erbil MK; Poyraz F; Okyay K; Turfan M; Cemri M
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethlyarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Menevşe E
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):84; author reply 84. PubMed ID: 18258550
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB; Erdem A; Yalta K; Turgut OO; Yilmaz A; Tandogan I
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.
    Celik T; Yuksel UC; Iyisoy A; Kursaklioglu H; Ozcan O; Kilic S; Ozmen N; Isik E
    Int J Cardiol; 2007 Mar; 116(2):206-11. PubMed ID: 16822563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.
    Serg M; Kampus P; Kals J; Zagura M; Zilmer M; Zilmer K; Kullisaar T; Eha J
    Scand J Clin Lab Invest; 2012 Sep; 72(5):427-32. PubMed ID: 22708640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F
    J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients.
    Kaiser T; Heise T; Nosek L; Eckers U; Sawicki PT
    J Hypertens; 2006 Jul; 24(7):1397-403. PubMed ID: 16794490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and metabolic effects of cardioselective beta-adrenoblockers nebivolol and metoprolol in patients with hypertension and ischemic heart disease associated with type 2 diabetes].
    Makolkin VI; Akhmedova OO; Buval'tsev VI; Gavrilov IuV; Petriĭ VV
    Kardiologiia; 2003; 43(2):40-3. PubMed ID: 12891271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA.
    Heitmann J; Greulich T; Reinke C; Koehler U; Vogelmeier C; Becker HF; Schmidt AC; Canisius S
    Curr Med Res Opin; 2010 Aug; 26(8):1925-32. PubMed ID: 20560730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus.
    Mittermayer F; Pleiner J; Krzyzanowska K; Wiesinger GF; Francesconi M; Wolzt M
    Wien Klin Wochenschr; 2005 Dec; 117(23-24):816-20. PubMed ID: 16437318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does nebivolol improve endothelial dysfunction and will it rescue the reputation of the beta-blockers in the future?
    Celik T; Iyisoy A
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):388-9. PubMed ID: 18065334
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.
    Kandavar R; Higashi Y; Chen W; Blackstock C; Vaughn C; Sukhanov S; Sander GE; Roffidal LE; Delafontaine P; Giles TD
    J Am Soc Hypertens; 2011; 5(3):161-5. PubMed ID: 21251896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
    Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
    Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.